Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Medgenics Inc (NASDAQ:MDGN)

5.29
Delayed Data
As of Dec 06
 +0.27 / +5.38%
Today’s Change
3.09
Today|||52-Week Range
6.75
-12.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line-15.1M-17.1M-18.4M-38.0M
 
 
 
 
 
Depreciation145.0K177.0K225.0K240.0K
 
 
 
 
 
Total Other Cash Flow3.0M3.6M5.5M13.5M
 
 
 
 
 
Funds From Operations-11.9M-13.3M-12.7M-24.2M
 
 
 
 
 
Funds From/For Other Operating Expenses-3.3M-574.0K-511.0K162.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-8.6M-12.7M-12.2M-24.4M
 
 
 
 
 
 
InvestingCapital Expenditures-63.0K-186.0K-364.0K-187.0K
 
 
 
 
 
Fixed Asset Disposal0.003.0K1.0K0.00
 
 
 
Other Investing - Uses-5.0K0.000.000.00
 
 
Net Cash Flow Investing-68.0K-183.0K-363.0K-187.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale10.1M28.9M23.5M44.3M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing10.1M28.9M23.5M44.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.000.00----
 
Net Change In Cash1.4M16.0M10.9M19.7M